These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 37223030)

  • 1. Determination and characterization of molecular heterogeneity and precision medicine strategies of patients with pancreatic cancer and pancreatic neuroendocrine tumor based on oxidative stress and mitochondrial dysfunction-related genes.
    Cui Y; Yuan Q; Chen J; Jiang J; Guan H; Zhu R; Li N; Liu W; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1127441. PubMed ID: 37223030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
    Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
    Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
    J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
    [No Abstract]   [Full Text] [Related]  

  • 4. Multi-omics analyses based on genes associated with oxidative stress and phospholipid metabolism revealed the intrinsic molecular characteristics of pancreatic cancer.
    Wang H; Guo H; Sun J; Wang Y
    Sci Rep; 2023 Aug; 13(1):13564. PubMed ID: 37604837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
    Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
    BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of heterogeneous subtypes and a prognostic model for gliomas based on mitochondrial dysfunction and oxidative stress-related genes.
    Li J; Wang S; Chi X; He Q; Tao C; Ding Y; Wang J; Zhao J; Wang W
    Front Immunol; 2023; 14():1183475. PubMed ID: 37334354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Mitochondrial Dysfunction and Oxidative Stress Pathway-Based Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Wu Y; Zhang X; Wei X; Feng H; Hu B; Deng Z; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Liu J; Wang T
    Oxid Med Cell Longev; 2021; 2021():9939331. PubMed ID: 34868460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
    Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
    Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with
    Chen X; Yuan Q; Liu J; Xia S; Shi X; Su Y; Wang Z; Li S; Shang D
    Front Immunol; 2022; 13():985911. PubMed ID: 36311789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of neuroendocrine regulation- and metabolism-associated molecular features and prognostic indicators with aid to clinical chemotherapy and immunotherapy of patients with pancreatic cancer.
    Zhang B; Yuan Q; Zhang B; Li S; Wang Z; Liu H; Meng F; Chen X; Shang D
    Front Endocrinol (Lausanne); 2022; 13():1078424. PubMed ID: 36743929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondria-Related Transcriptome Characterization Associated with the Immune Microenvironment, Therapeutic Response and Survival Prediction in Pancreatic Cancer.
    Dong J; Liu J; Zhang B; Liang C; Hua J; Meng Q; Wei M; Wang W; Yu X; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the Immune Profile to the Immunoscore: Signatures for Improving Postsurgical Prognostic Prediction of Pancreatic Neuroendocrine Tumors.
    Wei M; Xu J; Hua J; Meng Q; Liang C; Liu J; Zhang B; Wang W; Yu X; Shi S
    Front Immunol; 2021; 12():654660. PubMed ID: 33968055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
    Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
    Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the Immune Subtypes for the Prediction of Metastasis in Pancreatic Neuroendocrine Tumors.
    Meng D; Zhao L; Liu J; Ge C; Zhang C
    Neuroendocrinology; 2023; 113(7):719-735. PubMed ID: 36871552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Senescence-Related Signature Predicts Prognosis and Characterization of Tumor Microenvironment Infiltration in Pancreatic Cancer.
    Hua H; Zheng C; Fan J; Li X; Xie W; Chen J; Yu C
    Biomed Res Int; 2022; 2022():1916787. PubMed ID: 36518628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive prognostic and immune analysis of a glycosylation related risk model in pancreatic cancer.
    Liu X; Shi J; Tian L; Xiao B; Zhang K; Zhu Y; Zhang Y; Jiang K; Zhu Y; Yuan H
    BMC Cancer; 2023 Dec; 23(1):1229. PubMed ID: 38097951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Constructing the Prognostic Model With Four DNA Methylation-Driven Genes in Pancreatic Cancer.
    Chen G; Long J; Zhu R; Yang G; Qiu J; Zhao F; Liu Y; Tao J; Zhang T; Zhao Y
    Front Cell Dev Biol; 2021; 9():709669. PubMed ID: 35087823
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy.
    Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R
    Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germline genetic variability in pancreatic cancer risk and prognosis.
    Gentiluomo M; Canzian F; Nicolini A; Gemignani F; Landi S; Campa D
    Semin Cancer Biol; 2022 Feb; 79():105-131. PubMed ID: 32818625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
    Cigrovski Berkovic M; Coppola A; Sesa V; Mrzljak A; Lai Q
    World J Gastroenterol; 2024 Feb; 30(7):759-769. PubMed ID: 38515954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.